Prisma Health-upstate

This study tested a combination of two immunotherapy drugs (durvalumab and tremelimumab) in people with advanced rare solid tumors that had not responded to standard treatments. The goal was to see if the drugs could shrink tumors and to check for side effects. The trial was term…

This study compared two ways to surgically fix unstable hand fractures: using a buried wire inside the bone versus a plate and screws on the outside. It included 25 adults with broken hand bones that needed surgery. The study was stopped early, so results are limited.

This study tested a drug called tazemetostat in people with advanced solid tumors that have a specific genetic change (ARID1A mutation). The drug works by blocking a protein (EZH2) that helps these tumors grow. The trial aimed to see if the drug could shrink tumors or stop them f…